亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial

医学 特奈特普酶 改良兰金量表 冲程(发动机) 基底动脉 随机对照试验 闭塞 心脏病学 纤溶剂 溶栓 内科学 优势比 外科 临床试验 麻醉 动脉 死亡率
作者
Rui Li,Xiaoxi Yao,Raul G. Nogueira,Guangxiong Yuan,Zhongjun Chen,Wenhuo Chen,Tingyu Yi,Youquan Ren,Junfeng Su,Hao Wang,Zhengfei Ma,Guoyong Zeng,Benxiao Wang,Ming Wei,Shunfu Jiang,Guodong Xiao,Cunfeng Song,Tao Cui,Yaxuan Sun,Yuwen Li
出处
期刊:JAMA [American Medical Association]
卷期号:336 (17): 1529-1529
标识
DOI:10.1001/jama.2026.15496
摘要

Importance: Whether intravenous tenecteplase before endovascular thrombectomy (EVT) improves outcomes in patients with basilar artery occlusion presenting 4.5 to 24 hours after stroke onset remains uncertain. Objective: To evaluate the efficacy and safety of intravenous tenecteplase before EVT vs EVT alone in patients with moderate to severe basilar artery occlusion admitted within 4.5 to 24 hours from stroke onset. Design, Setting, and Participants: This multicenter, open-label, blinded end point, randomized clinical trial was conducted at 40 stroke centers in China. Between March 16, 2023, and February 4, 2025, a total of 330 patients with moderate to severe basilar artery occlusion (National Institutes of Health Stroke Scale score ≥10) presenting within 4.5 to 24 hours from stroke onset to EVT-capable centers were enrolled. Final follow-up was completed on May 4, 2025. Interventions: Patients were randomized 1:1 via a centralized web server using a minimization method to receive either intravenous tenecteplase (bolus injection, 0.25 mg/kg; maximum, 25 mg) followed by EVT (n = 166) or EVT alone (n = 164). Main Outcomes and Measures: The primary outcome was functional independence (modified Rankin Scale score, 0-2) at 90 days. Safety outcomes included symptomatic intracranial hemorrhage and 90-day mortality. Results: Among 332 patients randomized, 2 withdrew consent. Of the remaining 330 patients (mean [SD] age, 66 [11] years; 241 males [73%]; 89 females [27%]), 329 completed 90-day follow-up. Of whom, 50 of 165 (30%) in the tenecteplase plus EVT group and 50 of 164 (30%) in the EVT alone group achieved functional independence (adjusted rate ratio, 0.92 [95% CI, 0.67 to 1.25]; risk difference, -0.18% [95% CI, -10.13% to 9.76%]). Symptomatic intracranial hemorrhage occurred in 8 patients (5%) in the tenecteplase plus EVT group and 6 (4%) in the EVT alone group. Mortality at 90 days was similar between the groups (66 [40%] vs 70 [43%], respectively). Conclusions and Relevance: Among patients with moderate to severe basilar artery occlusion admitted directly to EVT-capable centers who presented 4.5 to 24 hours after stroke onset, the addition of intravenous tenecteplase before EVT did not result in improved functional outcomes compared with EVT alone. Trial Registration: ClinicalTrials.gov Identifier: NCT05701956.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大的应助被Ruan采纳,获得10
4秒前
12秒前
迷路的皮皮虾完成签到,获得积分10
17秒前
Ruan发布了新的文献求助10
18秒前
兴奋的惮完成签到,获得积分10
21秒前
热爱科研的小海豹完成签到 ,获得积分10
24秒前
欢喜的铭完成签到,获得积分10
34秒前
49秒前
高高的城发布了新的文献求助10
52秒前
Maestro_S的应助被科研通管家采纳,获得10
1分钟前
彭于晏的应助被高高的城采纳,获得10
1分钟前
清爽的天川完成签到,获得积分10
1分钟前
1分钟前
1分钟前
呆萌雨完成签到,获得积分10
1分钟前
大胆蛟凤完成签到,获得积分10
1分钟前
迷人白桃完成签到,获得积分10
1分钟前
2分钟前
楓秋完成签到 ,获得积分10
2分钟前
mmyhn驳回了奔跑的应助
2分钟前
爱听歌鲂完成签到,获得积分10
2分钟前
2分钟前
3分钟前
英俊的铭的应助被科研通管家采纳,获得10
3分钟前
忧虑的怀曼完成签到,获得积分10
3分钟前
顺心安雁完成签到,获得积分10
3分钟前
李佳佳发布了新的文献求助10
3分钟前
mmyhn驳回了奔跑的应助
3分钟前
大熊完成签到 ,获得积分10
3分钟前
qin完成签到 ,获得积分10
3分钟前
3分钟前
光亮豌豆完成签到,获得积分10
3分钟前
无私的迎蓉完成签到,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
每天吃土发布了新的文献求助10
4分钟前
奔跑的应助被mmyhn采纳,获得10
4分钟前
汉堡包的应助被每天吃土采纳,获得10
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173088
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780437
捐赠科研通 7767172
什么是DOI,文献DOI怎么找? 3431536
关于科研通互助平台的介绍 2555678
邀请新用户注册赠送积分活动 2476675